High Immunohistochemical Expression of SETD5 as a Candidate Pathological Factor for Dedifferentiation and Prognosis in Liposarcoma.

Pathol Int · 2026 · PMC12835964 · PMID 41467459

Europe PMC DOI

hedged sentence

0.1500

closest p · 3.0× alpha

0.1500

boldest claim

The sentences

did not reach statistical significancep = 0.15not close (p > 0.1)

showed a trendp = 0.15not close (p > 0.1)

Although mitotic activity and vascular invasion showed a trend toward higher levels in the high SETD5 expression group, these differences did not reach statistical significance ( p = 0.15 and p = 0.12, respectively). 3.4.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.